TuHURA BIOSCIENCES, INC./NV Increase (Decrease) in Other Noncurrent Assets
TuHURA BIOSCIENCES, INC./NV (HURA) reported Increase (Decrease) in Other Noncurrent Assets of -$73.76 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$38.87K, a 127.37% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$34.90K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$185.57K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$39.80K, a 116.54% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in other noncurrent assets for fiscal 2025 was -$155.00K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in other noncurrent assets for fiscal 2024 was -$106.61K.
- TuHURA BIOSCIENCES, INC./NV increase (decrease) in other noncurrent assets for fiscal 2023 was -$151.17K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$38.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$73.76K 10-Q · filed 2026-08-14 | -$259.34K derived: sum of 3 quarters · filed 2026-08-14 | -$299.14K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$34.90K 10-Q · filed 2026-05-15 | -$220.47K derived: sum of 2 quarters · filed 2026-05-15 | -$260.27K derived: sum of 3 quarters · filed 2026-05-15 | -$118.28K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$185.57K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$225.38K derived: sum of 2 quarters · filed 2026-03-31 | -$83.39K derived: sum of 3 quarters · filed 2026-08-14 | -$155.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$39.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $102.19K derived: sum of 2 quarters · filed 2026-08-14 | $30.58K 10-Q · filed 2025-11-14 | -$229.32K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $141.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $70.38K 10-Q · filed 2026-08-14 | -$189.52K derived: sum of 3 quarters · filed 2026-08-14 | $51.15K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$71.61K 10-Q · filed 2026-05-15 | -$331.51K derived: sum of 2 quarters · filed 2026-05-15 | -$90.84K derived: sum of 3 quarters · filed 2026-05-15 | -$235.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$259.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$19.23K derived: sum of 2 quarters · filed 2026-03-31 | -$163.39K derived: sum of 3 quarters · filed 2026-03-31 | -$106.61K 10-K · filed 2026-03-31 |
| 2024-09-30 | $240.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $96.51K derived: sum of 2 quarters · filed 2025-11-14 | $153.28K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$144.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$87.39K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $56.78K 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$151.17K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |